Stockscreener 앱 받기
123.77
0.04%
0.05
시간 외 거래:
123.77
Nuvalent Inc 주식(NUVL)의 최신 뉴스
GSK (NYSE: GSK) makes $124 cash tender offer for Nuvalent (NUVL) shares - Stock Titan
Nuvalent (NUVL) supplements disclosures as $124 cash offer proceeds - Stock Titan
Nuvalent chief development officer Noci sells $2.84m in stock - Investing.com
Form 4 Nuvalent Inc For: 6 July By Investing.com - Investing.com Canada
Nuvalent (NUVL) CDO exercises options and sells 23,000 shares - Stock Titan
Nuvalent (NUVL) CFO sells 11,430 shares and exercises options under plan - Stock Titan
BRODSKY & SMITH SHAREHOLDER UPDATE: Notifying Investors of - GlobeNewswire
GSK acquires Nuvalent for $10.6 billion in oncology push - qz.com
Enterprise value to revenue forward of Nuvalent, Inc. – NASDAQ:NUVL - TradingView
NUVL News | NUVALENT INC-A (NASDAQ:NUVL) - ChartMill
Nuvalent Inc stock hits all-time high at 123.7 USD - Investing.com
Nuvalent Inc stock hits all-time high at 123.7 USD By Investing.com - Investing.com UK
Shareholder Alert: Ademi LLP investigates whether Nuvalent, Inc. is obtaining a Fair Price for Public Shareholders - GlobeNewswire
Nuvalent, Inc. (NASDAQ:NUVL) Short Interest Update - MarketBeat
NUVL (NASDAQ: NUVL) Form 144 lists insider sale of Class A Common - Stock Titan
Insider at Nuvalent (NUVL) exercises options and sells 5,500 shares - Stock Titan
GSK agrees to acquire Nuvalent, Inc. - Pennsylvania Business Report -
Halper Sadeh LLC is Investigating Whether LCII, NUVL, DAN, TMHC are Obtaining Fair Deals for their Shareholders - GlobeNewswire
Halper Sadeh LLC is Investigating Whether LCII, NUVL, DAN, TMHC are Obtaining Fair Deals for their Shareholders - GlobeNewswire Inc.
BRODSKY & SMITH SHAREHOLDER UPDATE: Notifying Investors of the Following Investigations: Nuvalent, Inc. (Nasdaq – NUVL), Dana Incorporated (NYSE – DAN), SUNation Energy, Inc. (Nasdaq – SUNE), Taylor Morrison Home Corporation (NYSETMH - GlobeNewswire
GSK plc (GSK) Launches Tender Offer to Acquire Nuvalent Inc. for $124 Per Share - Yahoo Finance
GSK ends £2bn buyback with shares near 2,000p; Nuvalent deal in focus - Bez Kabli
GSK trades close to analyst target after Nuvalent deal - Bez Kabli
Nuvalent, Inc.(NasdaqGS: NUVL) added to Russell 2000 Growth-Defensive Index - marketscreener.com
Nuvalent, Inc.(NasdaqGS: NUVL) added to Russell 2000 Defensive Index - marketscreener.com
(NUVL) and the Role of Price-Sensitive Allocations - Stock Traders Daily
GSK plc (LON:GSK) share price: 3% weekly gain puts Nuvalent tender deadline in view - Bez Kabli
GSK launches $124-a-share takeover bid for cancer biotech Nuvalent - Indian Pharma Post
GSK announces Nuvalent tender offer, shares supported by oncology push - Ad-hoc-news.de
Enterprise value to EBIT forward of Nuvalent, Inc. – NASDAQ:NUVL - TradingView
Price to sales forward of Nuvalent, Inc. – NASDAQ:NUVL - TradingView
Nuvalent, Inc. Class A Actuals & Estimates (NASDAQ:NUVL) - TradingView
Price to book forward of Nuvalent, Inc. – NASDAQ:NUVL - TradingView
Price to earnings forward of Nuvalent, Inc. Class A – FWB:5AX - TradingView
Are NUVL, CPRX, TMHC Obtaining Fair Deals for their Shareholders? - TradingView
NUVL Forecast — Price Target — Prediction for 2027 - TradingView
Price to book forward of Nuvalent, Inc. Class A – FWB:5AX - TradingView
Enterprise value to revenue forward of Nuvalent, Inc. Class A – FWB:5AX - TradingView
Price to sales forward of Nuvalent, Inc. Class A – FWB:5AX - TradingView
GSK shares unchanged as Nuvalent guidance puts pressure on $10.6 billion buyout - Bez Kabli
Enterprise value to EBITDA forward of Nuvalent, Inc. Class A – FWB:5AX - TradingView
$HAREHOLDER ALERT: The M&A Class Action Firm Continues to Investigate the Merger--TMHC, NUVL, AXTA, and PFLC - Sahm
Key facts: GSK $124 offer for Nuvalent; HIV shifts to injectables - TradingView
GSK commences tender offer for Nuvalent shares - MLex
GSK (NUVL) bidders launch $124.00 cash tender for Nuvalent shares - Stock Titan
GSK announces commencement of tender offer to acquire Nuvalent, Inc. - GSK
GSK Unit Launches Tender Offer for Nuvalent Acquisition - Moomoo
GSK Initiates Tender Offer for Nuvalent Shares - GuruFocus
GSK commences tender offer to acquire Nuvalent for $124 per share - Investing.com
NUVL Downgraded by Bernstein -- Price Target Lowered to $124 - GuruFocus
GSK launches tender offer for USD10.6 billion purchase of Nuvalent - London South East
GSK (NYSE: GSK) moves to acquire Nuvalent with $124/share cash tender offer - Stock Titan
GSK commences tender offer to acquire Nuvalent for $124 per share By Investing.com - Investing.com India
GSK, Nuvalent to submit premerger notification - MLex
Bernstein analysts have made a significant adjustment to their rating on Nuvalent, Inc., downgrading it from "Outperform" to "Market Perform." - Bitget
GSK Agreed to Acquire Nuvalent on June 9 - Moomoo
GSK Announces Tender Offer to Buy Nuvalent - Moomoo
GSK Announces Tender Offer To Acquire Nuvalent - TradingView
REGGSK PLCGSK announces tender offer to acquire Nuvalent - TradingView
Nuvalent (NUVL) Board Recommends $124 Cash Offer from GSK Affiliated Buyer - Stock Titan
GSK plc (NUVL) offers $124.00 per share in cash tender for Nuvalent - Stock Titan
Bernstein Initiates Nuvalent(NUVL.US) With Hold Rating, Announces Target Price $124 - Moomoo
Bernstein downgrades Nuvalent stock rating on GSK acquisition deal - Investing.com
Bernstein downgrades Nuvalent stock rating on GSK acquisition deal By Investing.com - Investing.com South Africa
1.17%
2.48%
자본화:
|
볼륨(24시간):